United States · FDA National Drug Code directory
Treprostinil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0703-0696_c7be0baa-694d-498d-a474-3611f7773954
- Product NDC
- 0703-0696
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Treprostinil
- Labeler
- Teva Parenteral Medicines, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190930
- Source listing expiry
- 20261231
Source-listed ingredients
- TREPROSTINIL — 200 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (0703-0696-01) / 20 mL in 1 VIAL, MULTI-DOSE · 0703-0696-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →